Although VIP infusion did not induce migraine attacks, VIP levels were elevated in patients with CM who exhibited increased cranial parasympathetic system activity during migraine attacks, as well as patients with EM and patients with CM during interictal periods. This evidence concerns the gene VIP and migraine disorder.